Dyskeratosis congenita, telomeres and human ageing

Trends in Genetics

Volumn 16, Issue 5, 2000, Pages 193-195

  Marciniak, Robert A ^a,b,d   Johnson, F Brad ^a,c,d   Guarente, Leonard ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYSKERIN; TELOMERASE; UNCLASSIFIED DRUG;

AGING; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER; CELL PROLIFERATION; CYTOCHEMISTRY; DYSKERATOSIS CONGENITA; ENZYME ACTIVITY; GENE LOCUS; HUMAN; HUMAN CELL; KNOCKOUT MOUSE; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOLUS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; TELOMERE;

EID: 0034192063     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-9525(00)01984-3     Document Type: Short Survey

References (33)

1. Dokal I. Dyskeratosis congenita. Br. J. Haematol. 105:1999;11-15.
2. Drachtman R.A., Alter B.P. Dyskeratosis congenita. Derm. Clinics. 13:1995;33-39.
3. Luzzatto L., Karadimitris A. Dyskeratosis congenita and ribosomal rebellion. Nat. Genet. 19:1998;6-7.
4. Dokal I.et al. Dyskeratosis congenita fibroblasts are abnormal and have unbalanced chromosomal rearrangements. Blood. 80:1992;3090-3096.
5. Marsh J.C.et al. `Stem cell' origin of the hematopoietic defect in dyskeratosis congenita. Blood. 79:1992;3138-3144.
6. Devriendt K.et al. Skewed X-chromosome inactivation in female carriers of dyskeratosis congenita. Am. J. Hum. Genet. 60:1997;581-587.
7. Vulliamy T.J.et al. Skewed X-inactivation in carriers of X-linked dyskeratosis congenita. Blood. 90:1997;2213-2216.
8. Davidson H.R., Connor J.M. Dyskeratosis congenita. J. Med. Genet. 25:1988;843-846.
9. Heiss N.S.et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat. Genet. 19:1998;32-38.
10. Heiss N.S.et al. Dyskerin localizes to the nucleolus and its mislocalization is unlikely to play a role in the pathogenesis of dyskeratosis congenita. Hum. Mol. Genet. 8:1999;2515-2524.
11. Lafontaine D.L.J.et al. The box H+ACA snoRNAs carry Cbf5p, the putative rRNA pseudo-uridine synthase. Genes Dev. 12:1998;527-537.
12. Mitchell J.R.et al. A telomerase component is defective in the human disease dyskeratosis congenita. Nature. 492:1999;551-555.
13. Mitchell J.R.et al. A box H/ACA small nucleolar RNA-like domain at the human telomerase RNA 3′ end. Mol. Cell. Biol. 19:1999;567-576.
14. Campisi J. The biology of replicative senescence. Eur. J. Cancer. 33:1997;703-709.
15. Bodnar A.et al. Extension of life-span by introduction of telomerase into normal human cells. Science. 279:1998;349-352.
16. Blasco M.A.et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell. 91:1997;25-34.
17. Rudolph K.L.et al. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell. 96:1999;701-712.
18. Herrera E.et al. Disease states associated with telomerase deficiency appear earlier in mice with short telomeres. EMBO J. 18:1999;2950-2960.
19. Globerson A. Hematopoietic stem cells and aging. Exp. Gerontol. 34:1999;137-146.
20. Broccoli D.et al. Telomerase activity in normal and malignant hematopoetic cells. Proc. Natl. Acad. Sci. U. S. A. 92:1995;9082-9086.
21. Counter C.et al. Telomerase activity in normal lymphocytes and in hematologic malignancies. Blood. 1995;2315-2320.
22. Yasumoto S.et al. Telomerase activity in normal human epithelial cells. Oncogene. 13:1996;433-439.
23. Harle-Bachor C., Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis inhuman skin and in immortal and carcinoma-derived skin keratinocytes. Proc. Natl. Acad. Sci. U. S. A. 93:1996;6476-6481.
24. Hiyama E.et al. Telomerase activity in human intestine. Int. J. Oncol. 9:1996;453-458.
25. Blasco M.A.et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell. 91:1997;25-34.
26. Counter C.M.et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11:1992;1921-1929.
27. Chin L.et al. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell. 97:1999;527-538.
28. Herbert B.S.et al. Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. Proc. Natl. Acad. Sci. U. S. A. 96:1999;14276-14281.
29. de Lange T., Jacks T. For better or worse? Telomerase inhibition and cancer. Cell. 98:1999;273-275.
30. Allsopp R.C.et al. Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 89:1992;10114-10118.
31. Arking R. Biology of Aging: Observations and Principles. 1998;Sinauer.
32. Timiras P.S. Physiological Basis of Aging and Geriatrics. 1994;CRC Press.
33. -/- embryos is associated with failure to close the neural tube. EMBO J. 18:1999;1172-1181.